UPDATE: Citi Downgrades Quest Diagnostics (DGX) to Neutral on Uncertain Model Post-COVID
Tweet Send to a Friend
(Updated - April 4, 2022 7:13 AM EDT)
Citi analyst Ralph Giacobbe downgraded Quest Diagnostics (NYSE: DGX) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Ralph Giacobbe downgraded Quest Diagnostics (NYSE: DGX) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
